Search Results

Tolvaptan 25 mg  | ≥98%

LKT Laboratories, Inc.

V2 antagonist.

More Information Supplier Page

×

Tolvaptan

Silodosin 500 mg  | ≥98%

LKT Laboratories, Inc.

α1A-adrenergic antagonist.

More Information Supplier Page

×

Silodosin

Silodosin 100 mg  | ≥98%

LKT Laboratories, Inc.

α1A-adrenergic antagonist.

More Information Supplier Page

×

Silodosin

Silodosin 25 mg  | ≥98%

LKT Laboratories, Inc.

α1A-adrenergic antagonist.

More Information Supplier Page

×

Silodosin

Pixantrone Dimaleate 100 mg  | ≥98%

LKT Laboratories, Inc.

Aza-anthracenedione, DNA intercalator; topoisomerase II inhibitor.

More Information Supplier Page

×

Pixantrone Dimaleate

Valganciclovir Hydrochloride 100 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (deoxyguanosine) analog, ganciclovir prodrug; DNA chain elongation inhibitor.

More Information Supplier Page

×

Valganciclovir Hydrochloride

Vardenafil Dihydrochloride 10 mg  | ≥98%

LKT Laboratories, Inc.

PDE5 inhibitor.

More Information Supplier Page

×

Vardenafil Dihydrochloride

Rofecoxib 100 mg  | ≥98%

LKT Laboratories, Inc.

NSAID; COX-2 inhibitor.

More Information Supplier Page

×

Rofecoxib

Gemifloxacin Mesylate 25 g  | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; bacterial DNA gyrase inhibitor.

More Information Supplier Page

×

Gemifloxacin Mesylate

Gemifloxacin Mesylate 5 g  | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; bacterial DNA gyrase inhibitor.

More Information Supplier Page

×

Gemifloxacin Mesylate